Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
Berke K, Constantinescu G, Masjkur J, Kimpel O, Dischinger U, Peitzsch M, Kwapiszewska A, Dobrowolski P, Nölting S, Reincke M, Beuschlein F, Bornstein SR, Prejbisz A, Lenders JWM, Fassnacht M, Eisenhofer G.
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1181-e1192. doi: 10.1210/clinem/dgab751.
[Update on the risk of corticosterone therapy in combination with abiraterone acetate during the COVID-19 pandemic].
Rozet F, Mongiat-Artus P, Ploussard G, Rouprêt M, Cacoub P, Fournier G, Mathieu R.
Prog Urol. 2021 Apr;31(5):243-244. doi: 10.1016/j.purol.2020.12.002. Epub 2020 Dec 10.
Pharmacology of vorozole.
Wouters W, Van Ginckel R, Krekels M, Bowden C, De Coster R.
J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):617-21. doi: 10.1016/0960-0760(93)90268-2.
Brainstem prolactin-releasing peptide contributes to cancer anorexia-cachexia syndrome in rats.
Navarro I Batista K, Schraner M, Riediger T.
Neuropharmacology. 2020 Dec 1;180:108289. doi: 10.1016/j.neuropharm.2020.108289. Epub 2020 Sep 2.
Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
Borges KS, Pignatti E, Leng S, Kariyawasam D, Ruiz-Babot G, Ramalho FS, Taketo MM, Carlone DL, Breault DT.
Oncogene. 2020 Jul;39(30):5282-5291. doi: 10.1038/s41388-020-1358-5. Epub 2020 Jun 19.
Host endocrine responses during tumor growth.
Besedovsky H, del Rey A, Normann SJ.
Prog Clin Biol Res. 1989;288:203-13.
P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model.
Batisse-Lignier M, Sahut-Barnola I, Tissier F, Dumontet T, Mathieu M, Drelon C, Pointud JC, Damon-Soubeyrand C, Marceau G, Kemeny JL, Bertherat J, Tauveron I, Val P, Martinez A, Lefrançois-Martinez AM.
Oncogene. 2017 Aug;36(31):4445-4456. doi: 10.1038/onc.2017.54. Epub 2017 Apr 3.
Aldosterone-, corticosterone- and cortisol-secreting adrenocortical carcinoma in a dog: case report.
Machida T, Uchida E, Matsuda K, Hirayama K, Yoshii K, Takiguchi M, Taniyama H.
J Vet Med Sci. 2008 Mar;70(3):317-20. doi: 10.1292/jvms.70.317.
Recovery of adrenal function after treatment of adrenocortical carcinoma with o,p'-DDD.
Greig F, Oberfield SE, Levine LS, Ghavimi F, Pang S, New MI.
Clin Endocrinol (Oxf). 1984 Apr;20(4):389-99. doi: 10.1111/j.1365-2265.1984.tb03434.x.
Intracerebral interleukin-1beta impairs response to tumor invasion: involvement of adrenal catecholamines.
Hodgson DM, Yirmiya R, Chiappelli F, Taylor AN.
Brain Res. 1999 Jan 16;816(1):200-8. doi: 10.1016/s0006-8993(98)01185-8.
